ClinVar Miner

Submissions for variant NM_000455.5(STK11):c.772del (p.Asp258fs)

dbSNP: rs1599927589
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV001001057 SCV001158178 pathogenic not specified 2019-02-07 criteria provided, single submitter clinical testing The STK11 c.772delG; p.Asp258fs variant, to our knowledge, is not reported in the medical literature or gene specific databases in association with Peutz-Jeghers syndrome, though one study observed this variant in a fibrotic lung cancer sample (Guyard 2017). This variant is absent from general population databases (Exome Variant Server, Genome Aggregation Database), indicating it is not a common polymorphism. This variant causes a frameshift by deleting a single nucleotide, so it is predicted to result in a truncated protein or mRNA subject to nonsense-mediated decay. Additionally, STK11 loss-of-function is a known mechanism of disease, and truncating variants downstream of the p.Asp258fs variant have been reported in individuals diagnosed with Peutz-Jeghers syndrome (Borun 2013, Lim 2004). Based on available information, this variant is considered to be pathogenic. References: Borun P et al. High Resolution Melting analysis as a rapid and efficient method of screening for small mutations in the STK11 gene in patients with Peutz-Jeghers syndrome. BMC Med Genet. 2013 May 30;14:58. Guyard et al. Morphologic and molecular study of lung cancers associated with idiopathic pulmonary fibrosis and other pulmonary fibroses. Respir Res. 2017 Jun 15;18(1):120. Lim W et al. Relative frequency and morphology of cancers in STK11 mutation carriers. Gastroenterology. 2004 Jun;126(7):1788-94.
Invitae RCV001860501 SCV002200897 pathogenic Peutz-Jeghers syndrome 2022-04-07 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Asp258Thrfs*29) in the STK11 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in STK11 are known to be pathogenic (PMID: 15188174, 16287113). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with STK11-related conditions. ClinVar contains an entry for this variant (Variation ID: 811295). For these reasons, this variant has been classified as Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.